{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:00:33Z","timestamp":1764687633679},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T00:00:00Z","timestamp":1395792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s12185-014-1563-5","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T10:36:40Z","timestamp":1395743800000},"page":"777-781","source":"Crossref","is-referenced-by-count":1,"title":["Pure red cell aplasia complicating the course of long-standing mantle cell lymphoma"],"prefix":"10.1007","volume":"99","author":[{"given":"Alexander","family":"Kanellopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Koutsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Themis","family":"Ntalagiorgos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyriaki","family":"Petevi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Boutsikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loula","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Gainaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pagona","family":"Flevari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria K.","family":"Angelopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Meletis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodoros P.","family":"Vassilakopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,26]]},"reference":[{"key":"1563_CR1","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1182\/blood.V87.11.4831.bloodjournal87114831","volume":"87","author":"RJ Charles","year":"1996","unstructured":"Charles RJ, Sabo KM, Kidd PG, Abkowitz JL. The pathophysiology of pure red cell aplasia: implications for therapy. Blood. 1996;87:4831\u20138.","journal-title":"Blood"},{"key":"1563_CR2","first-page":"383","volume-title":"Hematology basic principles and practice","author":"JP Maciejewski","year":"2013","unstructured":"Maciejewski JP, Tiu RV. Acquired disorders of red cell and white cell production. In: Hoffman R, Benz EJ, Silberstein EL, Heslop HE, Weitz JR, Anastasi J, editors. Hematology basic principles and practice. 6th ed. Philadelphia: Elsevier Saunders; 2013. p. 383\u20139.","edition":"6"},{"key":"1563_CR3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12185-008-0158-4","volume":"88","author":"\u0395 Vlachaki","year":"2008","unstructured":"Vlachaki \u0395, Tselios \u039a, Charalambidou S, Ioannidou E, Klonizakis I. Pure red cell aplasia complicating B cell small lymphocytic lymphoma: a case report. Int J Hematol. 2008;88:341\u20132.","journal-title":"Int J Hematol"},{"key":"1563_CR4","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.4076\/1757-1626-2-6913","volume":"2","author":"\u0391 Anastasiadis","year":"2009","unstructured":"Anastasiadis \u0391, Margaritis D, Kotsianidis I, Spanoudakis E, Christoforidou A, Kostopoulos I, et al. Pure red cell aplasia as first manifestation of splenic marginal zone lymphoma-successful treatment with rituximab: a case report. Cases J. 2009;2:6913.","journal-title":"Cases J"},{"key":"1563_CR5","doi-asserted-by":"crossref","first-page":"475313","DOI":"10.1100\/2012\/475313","volume":"2012","author":"E Vlachaki","year":"2012","unstructured":"Vlachaki E, Diamantidis MD, Klonizakis P, Haralambidou-Vranitsa S, Ioannidou-Papagiannaki E, Klonizakis I. Pure red cell aplasia and lymphoproliferative disorders: an infrequent association. Sci World J. 2012;2012:475313.","journal-title":"Sci World J"},{"key":"1563_CR6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1080\/10428190701385173","volume":"48","author":"AW Hauswirth","year":"2007","unstructured":"Hauswirth AW, Skrabs C, Schutzinger C, Gaiger A, Lechner K, Jager U. Autoimmune hemolytic anemias, Evans\u2019 syndromes, and pure red cell aplasia in non-Hodgkin lymphomas. Leuk Lymphoma. 2007;48:1139\u201349.","journal-title":"Leuk Lymphoma"},{"key":"1563_CR7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajh.21354","volume":"84","author":"M Hirokawa","year":"2009","unstructured":"Hirokawa M, Sawada K, Fujishima N, Kawano F, Kimura A, Watanabe T, et al. Acquired pure red cell aplasia associated with malignant lymphomas: a nationwide cohort study in Japan for the PRCA Collaborative Study Group. Am J Hematol. 2009;84:144\u20138.","journal-title":"Am J Hematol"},{"key":"1563_CR8","unstructured":"Swerdlow SH, Campo E, Seto M, M\u00fcller-Hermelink HK. Mantle cell lymphoma. In: Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, \u03a4hiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th edn. International Agency for Research on Cancer (IARC), 2008."},{"key":"1563_CR9","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/sj.leu.2403413","volume":"18","author":"P Korkolopoulou","year":"2004","unstructured":"Korkolopoulou P, Vassilakopoulos TP. Topoisomerase IIalpha as a prognostic factor in mantle cell lymphoma. Leukemia. 2004;18:1347\u20139.","journal-title":"Leukemia"},{"key":"1563_CR10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/bjh.12409","volume":"162","author":"KA Hohenstaufen Von","year":"2013","unstructured":"Von Hohenstaufen KA, Conconi A, de Campos CP, Franceschetti S, Bertoni F, Margiotta Casaluci G, et al. Prognostic impact of monocyte count at presentation in mantle cell lymphoma. Br J Haematol. 2013;162:465\u201373.","journal-title":"Br J Haematol"},{"key":"1563_CR11","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1200\/JCO.2005.01.1825","volume":"23","author":"JE Romaguera","year":"2005","unstructured":"Romaguera JE, Fayad L, Rodriguez MA, Broglio KR, Hagemeister FB, Pro B, et al. High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine. J Clin Oncol. 2005;23:7013\u201323.","journal-title":"J Clin Oncol"},{"key":"1563_CR12","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1182\/blood-2004-10-3883","volume":"105","author":"M Dreyling","year":"2005","unstructured":"Dreyling M, Lenz G, Hoster E, Van Hoof A, Gisselbrecht C, Schmits R, et al. Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network. Blood. 2005;105:2677\u201384.","journal-title":"Blood"},{"key":"1563_CR13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/10428194.2010.534518","volume":"52","author":"S Sachanas","year":"2011","unstructured":"Sachanas S, Pangalis GA, Vassilakopoulos TP, Korkolopoulou P, Kontopidou FN, Athanasoulia M, et al. Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimen. Leuk Lymphoma. 2011;52:387\u201393.","journal-title":"Leuk Lymphoma"},{"key":"1563_CR14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3109\/10428194.2012.733882","volume":"54","author":"M Dreyling","year":"2013","unstructured":"Dreyling M, Kluin-Nelemans HC, Be\u00e0 S, Klapper W, Vogt N, Delfau-Larue MH, et al. Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network. Leuk Lymphoma. 2013;54:699\u2013707.","journal-title":"Leuk Lymphoma"},{"key":"1563_CR15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1200920","volume":"367","author":"HC Kluin-Nelemans","year":"2012","unstructured":"Kluin-Nelemans HC, Hoster E, Hermine O, Walewski J, Trneny M, Geisler CH, et al. Treatment of older patients with mantle-cell lymphoma. N Engl J Med. 2012;367:520\u201331.","journal-title":"N Engl J Med"},{"key":"1563_CR16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1034\/j.1600-0609.2002.00551.x","volume":"68","author":"MK Angelopoulou","year":"2002","unstructured":"Angelopoulou MK, Siakantaris MP, Vassilakopoulos TP, Kontopidou FN, Rassidakis GZ, Dimopoulou MN, et al. The splenic form of mantle cell lymphoma. Eur J Haematol. 2002;68:12\u201321.","journal-title":"Eur J Haematol"},{"key":"1563_CR17","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","volume":"70","author":"V Fern\u00e0ndez","year":"2010","unstructured":"Fern\u00e0ndez V, Salamero O, Espinet B, Sol\u00e9 F, Royo C, Navarro A, et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res. 2010;70:1408\u201318.","journal-title":"Cancer Res"},{"key":"1563_CR18","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","volume":"101","author":"J Orchard","year":"2003","unstructured":"Orchard J, Garand R, Davis Z, Babbage G, Sahota S, Matutes E, et al. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, non nodal disease. Blood. 2003;101:4975\u201381.","journal-title":"Blood"},{"key":"1563_CR19","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3324\/haematol.2010.036277","volume":"96","author":"SL Ondrejka","year":"2011","unstructured":"Ondrejka SL, Lai R, Kumar N, Smith SD, Hsi ED. Indolent mantle cell leukemia: clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, \u03ba light chain restriction, and good prognosis. Haematologica. 2011;96:1221\u20137.","journal-title":"Haematologica"},{"key":"1563_CR20","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1200\/JCO.2008.19.6121","volume":"27","author":"P Martin","year":"2009","unstructured":"Martin P, Chadburn A, Christos P, Weil K, Furman RR, Ruan J, et al. Outcome of deferred initial therapy in mantle-cell lymphoma. J Clin Oncol. 2009;27:1209\u201313.","journal-title":"J Clin Oncol"},{"key":"1563_CR21","doi-asserted-by":"crossref","unstructured":"Li G, Li ZQ, Yang QY, Yang JD. Acquired pure red cell aplasia due to treatment with clopidogrel: first case report. J Thromb Thrombolysis. 2013 (Epub ahead of print).","DOI":"10.1007\/s11239-013-1031-8"},{"key":"1563_CR22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0145-2126(90)90136-W","volume":"14","author":"R Alter","year":"1990","unstructured":"Alter R, Joshi S, Verdirame JD, Weisenburger DD. Pure red cell aplasia associated with B cell lymphoma: demonstration of bone marrow colony inhibition by serum immunoglobulin. Leuk Res. 1990;14:279\u201386.","journal-title":"Leuk Res"},{"key":"1563_CR23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199901283400405","volume":"340","author":"R Handgretinger","year":"1999","unstructured":"Handgretinger R, Geiselhart A, Moris A, Grau R, Teuffel O, Bethge W, et al. Pure red cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors. N Engl J Med. 1999;340:278\u201384.","journal-title":"N Engl J Med"},{"key":"1563_CR24","unstructured":"Dessypris EN, Lipton JM. Red cell aplasia. \u0399n: Greer JP, Foerster J, Lukens JN, Rogers GM, Paraskevas MD, Glader B, editors. Wintrobe\u2019s Clinical Hematology, 12th edn. Philadelphia: Lippincott, Williams & Wilkins, 2009:1196\u201311."},{"key":"1563_CR25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000203718","volume":"96","author":"T Higuchi","year":"1996","unstructured":"Higuchi T, Mori H, Niikura H, Omine M. Hypocomplementemia and hematological abnormalities in immunoblastic lymphadenopathy and immunoblastic lymphadenopathy-like T cell lymphoma. Acta Haematol. 1996;96:68\u201372.","journal-title":"Acta Haematol"},{"key":"1563_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V82.1.1.bloodjournal8211","volume":"82","author":"TP Loughran","year":"1993","unstructured":"Loughran TP. Clonal diseases of large granular lymphocytes. Blood. 1993;82:1\u201314.","journal-title":"Blood"},{"key":"1563_CR27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00277-006-0202-5","volume":"86","author":"M Dungarwalla","year":"2007","unstructured":"Dungarwalla M, Marsh JCW, Tooze JA, Lucas G, Ouwehand W, Petengell R, et al. Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology. Ann Hematol. 2007;86:191\u20137.","journal-title":"Ann Hematol"},{"key":"1563_CR28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.imlet.2012.12.006","volume":"150","author":"Y Michishita","year":"2013","unstructured":"Michishita Y, Hirokawa M, Fujishima N, Abe Y, Fujishima M, Guo Y-M, et al. CDR3-independent expansion of V\u03b41 \u03a4 lymphocytes in acquired chronic pure red cell aplasia. Immunol Let. 2013;150:23\u20139.","journal-title":"Immunol Let"},{"key":"1563_CR29","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood.V99.3.1092","volume":"99","author":"H Ghazal","year":"2002","unstructured":"Ghazal H. Succesful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia. Blood. 2002;99:1092\u20134.","journal-title":"Blood"},{"key":"1563_CR30","first-page":"730131","volume":"2013","author":"G D\u2019Arena","year":"2013","unstructured":"D\u2019Arena G, Guariglia R, La Rocca F, Trino S, Condelli V, DeMartino L, et al. Autoimmune cytopenias in chronic lymphocytic leukemia. Clin Dev Immunol. 2013;2013:730131.","journal-title":"Clin Dev Immunol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1563-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-014-1563-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1563-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T19:47:33Z","timestamp":1597607253000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-014-1563-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,26]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["1563"],"URL":"https:\/\/doi.org\/10.1007\/s12185-014-1563-5","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,26]]}}}